|
Reykjavik, Iceland, December 30, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, December 6, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, December 5, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, Nov 10 2005
|
|
|
|
Major discovery with rapid applicability
to the development of new medicine
|
|
|
| |
|
Reykjavik, Iceland, November 7, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, October 26, 2005
|
|
deCODE
genetics Announces Webcast of Conference Call to Discuss
Third Quarter Financial Results
|
|
|
|
|
| |
|
Reykjavik, Iceland, October 17, 2005
|
|
deCODE
genetics to Webcast Presentations at Upcoming Investor
Conferences
|
|
|
|
|
| |
|
Reykjavik, Iceland, September 8, 2005
|
|
deCODE
genetics to Webcast Presentation at the ThinkEquity Partners
Third Annual Growth Conference
|
|
|
|
|
| |
|
August 17, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, August 2, 2005
|
|
|
|
Progress in clinical and preclinical
programs, senior drug development appointments, strong
cash position underscore execution of product strategy
|
|
|
| |
|
Reykjavik, Iceland, July 25, 2005
|
|
deCODE
genetics Announces Webcast of Conference Call to Discuss
Second Quarter Financial Results
|
|
|
|
|
| |
|
Reykjavik, Iceland, July 19, 2005
|
|
|
|
|
|
|
| |
|
July 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, June 27, 2005
|
|
|
|
Advancing clinical pipeline in major
indications; unique capabilities in human genetics driving
broadening preclinical portfolio
|
|
|
| |
|
Reykjavik, Iceland, May 31, 2005
|
|
deCODE
genetics to Webcast Presentation at the Pacific Growth
Equities Life Science Growth Conference
|
|
|
|
|
| |
|
Reykjavik, Iceland, May 18, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, May 17, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, May 10, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, May 2, 2005
|
|
|
|
Advancing clinical development of
compounds for heart attack, atherosclerosis, asthma; company
has $197.6 million in cash and investments
|
|
|
| |
|
Reykjavik, Iceland, April 26, 2005
|
|
deCODE
genetics to Webcast Presentations at Upcoming Deutsche
Bank and Morgan Stanley Investor Conferences
|
|
|
|
|
| |
|
Reykjavik, Iceland, April 25, 2005
|
|
deCODE
genetics Announces Webcast of Conference Call to Discuss
First Quarter Financial Results
|
|
|
|
|
| |
|
Reykjavik, Iceland, March 22, 2005
|
|
deCODE
genetics to Webcast Presentation at the Lehman Brothers
Eighth Annual Global Healthcare Conference
|
|
|
|
|
| |
|
Reykjavik, Iceland, March 9, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, March 7, 2005
|
|
deCODE
genetics to Webcast Presentation at the JPMorgan Small
Cap Conference
|
|
|
|
|
| |
|
Reykjavik, Iceland, March 3, 2005
|
|
|
|
Advancing clinical development of
therapeutics for heart attack, atherosclerosis, asthma
- Successfully focusing resources on advancing and expanding
drug development pipeline; $198 million in cash and investments
at year end
|
|
|
| |
|
Reykjavik, Iceland, February 18, 2005
|
|
deCODE
genetics Announces Webcast of Conference Call to Discuss
Full-year 2004 Financial Results
|
|
|
|
|
| |
|
Reykjavik, Iceland, February 17, 2005
|
|
deCODE
genetics to Webcast Presentation at the BIO CEO & Investor
Conference
|
|
|
|
|
| |
|
Reykjavik, Iceland, January
20, 2005
|
|
deCODE
genetics to Webcast Presentation at 17th Annual Piper
Jaffray Healthcare Conference
|
|
|
|
|
| |
|
January 16, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, January 13, 2005
|
|
|
|
|
|
|
| |
|
Reykjavik, Iceland, January 5, 2005
|
|
deCODE
genetics today announced that its presentation at the
23rd Annual JP Morgan Healthcare Conference will be webcast
live via streaming audio.
|
|
|
|
|
| |
deCODE
Announces Departure of Jean-Francois Formela from Board
of Directors 